PATENT CLAIM ANALYSIS

Application Number: 16062358
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "461000"]

Abstract:
Disclosed is a pharmaceutical composition including naftazone or one of its pharmaceutically acceptable salts, for its use for the pulsatile release of naftazone or one of its pharmaceutically acceptable salts, wherein: a first pulse of naftazone or one of its pharmaceutically acceptable salts is released substantially immediately upon oral administration of the pharmaceutical composition; and at least one additional pulse of naftazone or one of its pharmaceutically acceptable salts is released at about 3 hours to about 8 hours following the oral administration.

Claim (Index 33):
A method for treating Parkinson disease, comprising the administration of a pharmaceutical acceptable amount of the pharmaceutical composition of  claim 18  to a patient in need thereof.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 94.0
- Lexical Diversity: 2.09524
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14230053', '14841428', '14255529', '15076253', '14589839']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7295002532667091
- 35 USC 102 Novelty (BERT): 0.5214320379146965
- Combined Prediction Score: 0.7086934317315078
- Mean Citation Score: 298.387646
- Max Citation Score: 304.9656700000001
- Similarity Product: 177.62133849906212

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test